Volitionrx (VNRX) Notes Payables (2011 - 2025)
Volitionrx (VNRX) posted Notes Payables of $2.4 million for Q4 2025, up 657.26% on a QoQ basis from $319347.0 in Q3 2025.
Volitionrx (VNRX) Notes Payables (2011 - 2025) Analysis & Trends
Volitionrx's Notes Payables history runs 6 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- Quarterly Notes Payables changed N/A year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed N/A YoY) and the FY2025 annual result came in at $2.4 million, changed N/A from the prior year.
- Notes Payables was $2.4 million for Q4 2025 at Volitionrx, up from $319347.0 in the prior quarter.
- Across five years, Notes Payables topped out at $2.4 million in Q4 2025 and bottomed at $166522.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 319,347.00 |
| Jun 30, 2025 | 166,522.00 |
| Jun 30, 2019 | 79,589.00 |
| Dec 31, 2018 | 40,094.00 |
| Mar 31, 2013 | 49,982.00 |
| Dec 31, 2012 | 52,860.00 |
| Dec 31, 2011 | 155,268.00 |